Ponsegromab

3 trials 1 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

1 Sponsors

10 Countries

Phase II/III

Phase II

Phase II/III: 1 Phase II: 2

Oversight events:

1 urgent safety measure across 1 trial

View oversight register →

Sponsors using this IMP

All trials

3 total

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which has Spread and Caused Significant Body Weight Lo… Recruiting

2025-522093-36-00 Phase II/III 8 countries Pfizer Inc.
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PONSEGROMAB IN PATIENT… Ended

2023-510446-24-00 Phase II 4 countries Pfizer Inc.
A Phase 2 Study of the Effects of Ponsegromab on Health-Related Quality of Life and Safety in Patients With Heart Failure (GARDEN-TIMI 74) Ended

2023-509747-27-00 Phase II 5 countries Pfizer Inc.

Showing 1–3 of 3 trials

← All drugs A–Z